Quantitative Polymerase Chain Reaction Market - Global Forecast and Opportunity Assessment by Technavio

Technavio has published a new report on the global qPCR market from 2017-2021. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--The global quantitative polymerase chain reaction (qPCR) market is expected to grow at a CAGR of around 8% during the forecast period, according to Technavio’s latest report.

In this report, Technavio covers the market outlook and growth prospects of the global qPCR market for 2017-2021. The market is segmented based on application, which includes drug discovery and development, clinical diagnostics, and research laboratories.

PCR is a technique of molecular genetics, used for precise, specific, and accurate amplification and analysis of nucleic acid sequences. It is also used in a wide range of applications in research and diagnosis, such as genetic engineering, cloning, gene expression, sequencing, diagnosis, and genotyping. The two widely accepted technologies of PCR in the areas of research and diagnosis are quantitative polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR).

Technavio’s research analysts categorize the global quantitative polymerase chain reaction market into the following segments by regions:

  • Americas
  • EMEA
  • APAC

Americas: largest qPCR market

Factors such as the increase in public and private funding and increasing financial support from prominent funding agencies and federal institutions for the R&D of innovative qPCR are driving the market growth in North America. Thus, the major pharmaceutical and biotechnology companies are preferring to use advanced qPCR technologies and products, as they provide highly accurate, specific, and productive results,” says Amber Chourasia, a lead analyst at Technavio for research on lab equipment.

The qPCR market in the Americas is growing moderately due to the developed healthcare infrastructure and the presence of many pharmaceutical companies in the countries such as the US. The presence of a high number of pharmaceutical companies has led to the increased number of tests using various qPCR techniques related to new drug development and disease diagnosis, thus increasing the demand for qPCR in the region.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

qPCR market in EMEA

The outbreak of various diseases and scope of research in this region have led to the development of research laboratories and pharmacogenomics. This growth will lead to a rise in the demand for the qPCR market,” says Amber.

Europe leads the qPCR market in EMEA. Countries such as the UK, France, Italy, and Germany contribute the highest revenue in Europe. Many global and regional vendors are actively investing in the form of funding projects and research grants to develop PCR-based solutions related to various fields including agriculture and disease diagnosis. These are contributing toward the growth of the PCR technologies like qPCR.

qPCR market in APAC

The qPCR market in APAC is growing rapidly due to the increased investment in research by the governments in this region and the increased outsourcing activities by the vendors to the CRO industry to meet the increased demand. The CROs generally prefer to use the qPCR technology for rapid and accurate results to meet the high demand from the end-users. Moreover, the CRO industry is expanding its business in APAC, as the vendors are trying to reduce the cost of ownership by getting the tests and diagnostics done by the CROs.

The migration of R&D facilities to APAC by major vendors to penetrate the market with the solutions based on the requirements of APAC end-users at affordable prices will also be a driving factor for the growth of the market during the forecast period.

The top vendors in the global qPCR market highlighted in the report are:

  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Thermo Fisher Scientific

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like category spend intelligence and health and wellness. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

The global quantitative polymerase chain reaction (qPCR) market is expected to grow at a CAGR of around 8% during the forecast period, 2017-2021.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com